This week, The Long Run with Luke Timmerman examined the current state of biotech through a conversation with Jeremy Levin, exploring the industry's competing pressures and shifting landscape. The discussion touched on several critical tensions shaping the sector as it navigates funding challenges, regulatory dynamics, and strategic priorities. The episode offers perspective on where biotech stands and the decisions facing companies and investors in the months ahead.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top the long run with luke timmerman podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.